VINCERX PHARMA INC

CUSIP: 92731L106 Class: COM NEW

GEODE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001214717)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 241,517 Value ($000) $63 Avg Close — Range —
Q3 2024
Shares 250,800 Value ($000) $180 Avg Close — Range —
Q2 2024
Shares 230,785 Value ($000) $187 Avg Close — Range —
Q1 2024
Shares 182,483 Value ($000) $924 Avg Close — Range —
Q4 2023
Shares 154,031 Value ($000) $182 Avg Close — Range —
Q3 2023
Shares 154,031 Value ($000) $159 Avg Close — Range —
Q2 2023
Shares 136,878 Value ($000) $178 Avg Close — Range —
Q1 2023
Shares 136,878 Value ($000) $142 Avg Close — Range —
Q4 2022
Shares 136,878 Value ($000) $0 Avg Close — Range —
Q3 2022
Shares 137,191 Value ($000) $189 Avg Close — Range —
Q2 2022
Shares 137,191 Value ($000) $181 Avg Close — Range —
Q1 2022
Shares 269,410 Value ($000) $1,077 Avg Close — Range —
Q4 2021
Shares 245,469 Value ($000) $2,501 Avg Close — Range —
Q3 2021
Shares 217,798 Value ($000) $3,521 Avg Close — Range —
Q2 2021
Shares 150,772 Value ($000) $1,958 Avg Close — Range —
Q1 2021
Shares 93,959 Value ($000) $1,813 Avg Close — Range —